Publication Date

1-11-2024

Journal

Journal of Medicinal Chemistry

DOI

10.1021/acs.jmedchem.3c01834

PMID

38117688

PMCID

PMC11489902

PubMedCentral® Posted Date

1-11-2025

PubMedCentral® Full Text Version

Author MSS

Published Open-Access

yes

Keywords

beta-Lactamase Inhibitors, Anti-Bacterial Agents, beta-Lactamases, beta-Lactams, Penicillins, DNA, Microbial Sensitivity Tests

Abstract

β-Lactamase enzymes hydrolyze and thereby provide bacterial resistance to the important β-lactam class of antibiotics. The OXA-48 and NDM-1 β-lactamases cause resistance to the last-resort β-lactams, carbapenems, leading to a serious public health threat. Here, we utilized DNA-encoded chemical library (DECL) technology to discover novel β-lactamase inhibitors. We exploited the β-lactamase enzyme-substrate binding interactions and created a DECL targeting the carboxylate-binding pocket present in all β-lactamases. A library of 10

nihms_2025008_f0001.jpg (89 kB)
Graphical Abstract

Comments

Associated Data

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.